Karlijn Hummelink
5PUBLICATIONS
60CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 31, 2024
Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer.Karlijn Hummelink, Vincent van der Noort, Mirte Muller
|Feb 01, 2024
Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung Cancer.Joris van de Haar, Joanne M Mankor, Karlijn Hummelink
|Dec 13, 2023
A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non-small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics.Karlijn Hummelink, Renaud Tissier, Linda J W Bosch
|Nov 08, 2023
Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer.Joseph C Murray, Lavanya Sivapalan, Karlijn Hummelink
|Jul 19, 2022
PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC.Karlijn Hummelink, Vincent van der Noort, Mirte Muller
Pageof 1
Frequent Collaborators
4 joint publications
Kim Monkhorst
4 joint publications
Egbert F Smit
3 joint publications
Daniela S Thommen
3 joint publications
Michel M van den Heuvel
2 joint publications
Vincent van der Noort
2 joint publications
Robert D Schouten
2 joint publications
Willemijn S M E Theelen
2 joint publications
Gerrit A Meijer
1 joint publications
Mirte Muller
1 joint publications
Dennis Peters
